EDGAR Filing Documents for 0001213900-17-004433

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-17-004433

Filing Date

2017-05-01

Accepted

2017-05-01 13:36:41

Documents

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	f20f2016_therapixbiosciences.htm	20-F	2574655
2	LICENSE AGREEMENT DATED MARCH 30, 2017, BY AND BETWEEN THE COMPANY AND YISSUM RE	f20f2016ex4iii_therapix.htm	EX-4.3	413332
3	FORM OF INDEMNIFICATION AGREEMENT	f20f2016ex4xii_therapixbio.htm	EX-4.12	139032
4	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OF THE S	f20f2016ex12i_therapixbio.htm	EX-12.1	12672
5	CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO RULE	f20f2016ex12ii_therapixbio.htm	EX-12.2	11000
6	CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350	f20f2016ex13i_therapixbio.htm	EX-13.1	5778
7	CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO 18 U	f20f2016ex13ii_therapixbio.htm	EX-13.2	3908
8	GRAPHIC	ex4xii_01.jpg	GRAPHIC	9867
9	GRAPHIC	image_001.jpg	GRAPHIC	4643
	Complete submission text file	0001213900-17-004433.txt		3181698

Mailing Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002

Business Address SCIENCE PARK, 18 EINSTIEN ST. P.O BOX 4122 NESS-ZIONA L3 7414002 972-8-9396577

Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)